Cite
HARVARD Citation
England, J. et al. (2023). Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor. American journal of hematology. 98 (5), pp. E127-E129. [Online].